Lexicon Pharmaceuticals Inc.
LXRX | NASDAQ
$2.08
+$0.04 (+1.96%)
Sep 22, 2026, 11:26 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -8.21 | -1.17 | -1.91 | -3.08 | -6.46 | -5.43 |
PEG Ratio | 0.11 | 0.06 | -0.07 | -1.88 | 2.03 | 0.04 |
PS Ratio | 8.38 | 7.60 | 281 | 2.28K | 1.93K | 15.80 |
PB Ratio | 3.88 | 1.62 | 3.63 | 2.70 | 5.05 | 2.42 |
P/FCF Ratio | -6.15 | -1.31 | -2.08 | -3.51 | -6.50 | -2.65 |
P/OCF Ratio | -6.15 | -1.32 | -2.09 | -3.56 | -6.59 | -2.65 |
OCF/S Ratio | -136.24 | -575.21 | -13.45K | -63.92K | -29.2K | -595.83 |
Debt / Equity Ratio | 0.58 | 0.74 | 1.14 | 0.47 | 0.02 | 0.08 |
Quick Ratio | 4.87 | 5.44 | 5.58 | 6.08 | 4.02 | 3.37 |
Current Ratio | 4.88 | 5.44 | 5.60 | 6.08 | 4.02 | 3.37 |
Asset Turnover | 0.27 | 0.10 | 0.01 | 0 | 0 | 0.12 |
Interest Coverage | -5.87 | -12.65 | -13.11 | -36.24 | -108.59 | -3.29 |
Return on Equity | -46.81% | -137.31% | -190.23% | -87.04% | -77.26% | -37.46% |
Return on Assets | -27.21% | -67.15% | -77.20% | -52.47% | -64.10% | -28.74% |
Return on Invested Capital | -28.71% | -77.50% | -86.23% | -58.44% | -75.16% | -28.25% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 99.45% | 98.02% | -4.8K% | -37.68K% | -18.37K% | 91.96% |
Net Profit Margin | -101.08% | -644.78% | -14.71K% | -73.34K% | -29.45K% | -244.11% |
Pretax Profit Margin | -101.08% | -644.78% | -14.71K% | -73.34K% | -29.45K% | -244.11% |
Operating Profit Margin | -98.21% | -634.20% | -14.26K% | -72.49K% | -29.22K% | -199.21% |
FCF Margin | -136.24% | -578.52% | -13.49K% | -64.88K% | -29.61K% | -596.19% |
EBITDA Margin | -83.09% | -592.93% | -14.1K% | -71.97K% | -29.08K% | -171.27% |
Add to Watchlist
Select watchlists to add or remove LXRX